DIHYDROBENZOANTHRACENONE, -PYRIMIDINONE OR DIHYDRONAPHTOQUINOLINONE

摘要

Novel compounds having formula (I) wherein X,Y,R<1>,R<2>,R<3>,R<4> and R<5> have the meaning cited in claim 1, their salts and their solvates. Said compounds inhibit the binding of fibrinogens on the corresponding receptor and can for instance be used in the treatment of thromboses, osteoporoses, tumour diseases, apoplexia, heart attacks, ischemias, inflammations, arteriosclerosis and osteolytic diseases.